These ASX shares could rise 25% to 35%

Analysts are tipping these shares to rise strongly from where they trade today.

| More on:
a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you want to give your investment portfolio a nice boost, then it could be worth considering the ASX shares listed below.

That's because they have been named as buys and tipped to rise materially from current levels. Here's what you need to know about them:

James Hardie Industries plc (ASX: JHX)

Analysts at Goldman Sachs see a lot of value in this building materials company's shares following a recent pullback.

The broker notes that it sees "upside from cyclical improvement and strategic execution against higher value product mix targets, which has scope to substantially improve group profitability." It also highlights that its analysts "continue to expect robust growth in FY26 as North America volumes accelerate to 7%, while new construction and PDG maintain momentum."

In light of this, the broker put a buy rating and $57.85 price target on its shares earlier this month. This implies a potential upside of almost 25% for investors over the next 12 months.

Neuren Pharmaceuticals Ltd (ASX: NEU)

The team at Bell Potter is feeling very bullish about this pharmaceuticals company and sees it as an ASX share to buy right now.

The broker was pleased with the phase two results from its NNZ-2591 trial in Pitt Hopkins syndrome. It highlights that NNZ-2591 "has now shown encouraging clinical data in two indications, each of which represent a similar if not larger market opportunity than Rett syndrome."

In addition, with no approved treatments available, it believes that "NNZ-2591 is comfortably in poll position to be the first drug to market."

In response to the news, the broker has retained its buy rating with an improved price target of $28.00. This implies a potential upside of almost 35% for investors from current levels.

Woodside Energy Group Ltd (ASX: WDS)

A third ASX share that could deliver big returns for investors according to analysts is energy giant Woodside.

Morgans thinks investors should be snapping up the company's shares while they are down in the dumps. It notes that "with the pullback in oil prices moderating and work at Scarborough back underway, we see now as a good time to add to positions."

This is particularly the case given its belief that Woodside "will still generate substantial high-quality earnings for years to come."

Morgans has an add rating and a $36.00 price target on its shares. This implies a potential upside of 31% for investors from current levels. In addition, the broker is forecasting dividend yields of 4%+ in both FY 2024 and FY 2025, boosting the total potential 12-month return to over 35%.

Motley Fool contributor James Mickleboro has positions in Woodside Energy Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A young female investor sits in her home office looking at her ipad and smiling as she sees the QBE share price rising
Broker Notes

These four ASX All Ords shares just earned hefty broker upgrades. Here's why

The ASX All Ords shares are forecast to surge as much as 98% over the year ahead.

Read more »

A man in a suit looks serious while discussing business dealings with a couple as they sit around a computer at a desk in a bank home lending scenario.
Bank Shares

What's the outlook for the Westpac share price in FY25?

Top broker Goldman Sachs outlines three challenges for the ASX 200 bank in FY25.

Read more »

Man smiling at a laptop because of a rising share price.
Broker Notes

Macquarie shares have 10% upside: Morgan Stanley

Another bullish broker on Macquarie.

Read more »

A woman looks questioning as she puts a coin into a piggy bank.
Broker Notes

Is the ANZ share price 'the best value of the major banks'?

ANZ shares are in the green today.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Broker Notes

Buy 'em now! Brokers name 3 ASX All Ords shares to add to your portfolio

Copper, technology, and healthcare are the themes among these newly buy-rated stocks.

Read more »

a woman holds a facebook like thumbs up sign high above her head. She has a very happy smile on her face.
Broker Notes

Bell Potter says these ASX shares are strong buys

Big returns are expected from these shares over the next 12 months.

Read more »

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Broker Notes

Guess which ASX 300 share could rise over 50%

Bell Potter sees huge upside for this buy-rated stock. Let's see why it is bullish.

Read more »